Tag: Acquisition

Browse our exclusive articles!

Pathos AI Completes Tender Offer for Rain Oncology, Becomes Wholly Owned Subsidiary

Pathos AI completes tender offer for Rain Oncology, becoming wholly owned subsidiary. Strengthens position in biotech industry.

Tesla Misses Expectations, Stock Falls 10% as CEO Musk Shifts Focus to AI and Robotics

Tesla's stock price falls 25% in 2024 due to missed expectations, lower guidance, and competition in AI and robotics. Time to sell?

Tesla Misses Expectations, Lowers Guidance, and Faces Competition in AI and Robotics

Tesla's stock price falls 25% in 2024 due to missed expectations, lower guidance, and competition in AI and robotics. Time to sell?

Sanofi Acquires Inhibrx for $2.2bn to Advance Treatment for Rare Lung Disease

Sanofi acquires biopharmaceutical company Inhibrx in a $2.2 billion deal to advance treatment for rare lung disease AATD.

Synopsys to Acquire Ansys, Creating R&D Powerhouse in AI and Software-Defined Systems

Synopsys to acquire Ansys, creating an R&D powerhouse in AI and software-defined systems. $35 billion deal solidifies their market position. #EDA #AI

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img